Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 6 | 2016 | 955 | 0.800 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2018 | 2270 | 0.620 |
Why?
|
| Genome-Wide Association Study | 6 | 2018 | 1620 | 0.480 |
Why?
|
| Genetic Loci | 4 | 2018 | 250 | 0.450 |
Why?
|
| Kallikreins | 1 | 2012 | 47 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 59 | 0.440 |
Why?
|
| Alleles | 2 | 2016 | 1127 | 0.410 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 352 | 0.370 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 576 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 2356 | 0.160 |
Why?
|
| Rhinitis, Allergic | 1 | 2018 | 43 | 0.160 |
Why?
|
| HLA Antigens | 1 | 2018 | 232 | 0.150 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 105 | 0.130 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 144 | 0.130 |
Why?
|
| Dermatitis, Atopic | 1 | 2015 | 52 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 294 | 0.120 |
Why?
|
| Genome, Human | 1 | 2018 | 756 | 0.120 |
Why?
|
| Chimerism | 1 | 2013 | 37 | 0.110 |
Why?
|
| Genotype | 2 | 2016 | 1850 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 87 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2014 | 678 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2705 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 526 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1074 | 0.100 |
Why?
|
| Sex Factors | 1 | 2014 | 1054 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1920 | 0.070 |
Why?
|
| Risk | 2 | 2018 | 674 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2016 | 3611 | 0.060 |
Why?
|
| Humans | 8 | 2018 | 86601 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1804 | 0.050 |
Why?
|
| Risk Factors | 1 | 2012 | 5416 | 0.050 |
Why?
|
| Male | 5 | 2016 | 40956 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 532 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2015 | 673 | 0.050 |
Why?
|
| Female | 5 | 2016 | 44507 | 0.050 |
Why?
|
| Phenotype | 2 | 2018 | 2377 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2018 | 1351 | 0.050 |
Why?
|
| United States | 1 | 2012 | 6665 | 0.050 |
Why?
|
| Child | 3 | 2016 | 6926 | 0.040 |
Why?
|
| Allergens | 1 | 2018 | 179 | 0.040 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 84 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2015 | 51 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2015 | 48 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 63 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 151 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 223 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 473 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 302 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 379 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 503 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2011 | 20 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 8979 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 1531 | 0.020 |
Why?
|
| North America | 1 | 2011 | 180 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 1849 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1801 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1196 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3674 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1565 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 3045 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 2767 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 2893 | 0.020 |
Why?
|
| Adult | 2 | 2015 | 25640 | 0.020 |
Why?
|